Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Jerini Extends Pact With Baxter For New Hemophilia Drugs

Feb. 7, 2007

By Cormac Sheridan

ScanBalt Promoting Baltic Biotechnology Cooperation

Feb. 7, 2007

By Cormac Sheridan

ScanBalt Promoting Baltic Biotechnology Cooperation

Feb. 7, 2007

By Cormac Sheridan

Jerini Extends Pact With Baxter For New Hemophilia Drugs

Feb. 7, 2007

By Cormac Sheridan

GPC Biotech Banks $44M Toward Satraplatin Launch

Jan. 31, 2007

By Cormac Sheridan

GPC Biotech Banks $44M Toward Satraplatin Launch

Jan. 31, 2007

By Cormac Sheridan

Cosmo Gains FDA Approval For Delivery Technology

Jan. 24, 2007

By Cormac Sheridan

Affectis In-Licenses Cox-2 Inhibitor For Depression

Jan. 24, 2007

By Cormac Sheridan

Cosmo Gains FDA Approval For Delivery Technology

Jan. 24, 2007

By Cormac Sheridan

Affectis In-Licenses Cox-2 Inhibitor For Depression

Jan. 24, 2007

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...